HYBRID EVENT: You can participate in person at Rome, Itlay or Virtually from your home or work.

11th Edition of International Conference on

Neurology and Neurological Disorders

June 05-07, 2025 | Rome, Italy

Spinocerebellar Ataxia

Spinocerebellar Ataxia

Spinocerebellar ataxia (SCA) is a group of genetic disorders characterized by progressive damage to the cerebellum, the part of the brain responsible for balance and coordination. It is caused by a mutation on one of several genes associated with SCA, including SCA1, SCA2, SCA3, SCA6, and SCA7. Symptoms of SCA include unsteady and jerky movements, difficulty with speech and swallowing, and loss of coordination. The cause of SCA is linked to genetic mutations, which can be inherited or occur spontaneously. In familial cases, a family member likely inherited the mutation from a parent or developed it on his or her own. However, some forms of SCA can arise spontaneously. In these cases, SCA is not inherited from either parent and is not passed down to the next generation. The primary symptom of SCA is progressive loss of coordination, known as cerebellar ataxia. People with SCA may have difficulty walking or performing fine motor tasks like buttoning a shirt or writing. Balance, coordination, and speech can be affected, and people with SCA may experience tremors or spasms, trouble coordinating eye movements, and difficulty with swallowing. SCA has no cure, but therapy can help treat the condition and improve quality of life. Physical therapy can help maintain muscle strength and control, while occupational therapy can help with self-care activities and daily living skills. Medication can help control the symptoms, such as reducing tremors or spasms. Speech therapy can help with communication and swallowing, and assistive devices such as wheelchairs or walkers can help improve mobility. In addition, research is being conducted to better understand the genetics of SCA and how the condition works. This research is looking for potential treatments to slow the progression of SCA and improve quality of life for those affected.

Committee Members
Speaker at Neurology and Neurological Disorders 2025 - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute, Australia
Speaker at Neurology and Neurological Disorders 2025 - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
Speaker at Neurology and Neurological Disorders 2025 - Luiz Moutinho

Luiz Moutinho

University of Suffolk, United Kingdom
Neurology 2025 Speakers
Speaker at Neurology and Neurological Disorders 2025 - David Lominadze

David Lominadze

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Milton C R Medeiros

Milton C R Medeiros

Irmandade Santa Casa de Arapongas PR, Brazil
Speaker at Neurology and Neurological Disorders 2025 - Sang Hie Lee

Sang Hie Lee

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Sergei M Danilov

Sergei M Danilov

University of Illinois, United States

Submit your abstract Today

Watsapp